✦ LIBER ✦

Insulin-like growth factor I: a predictor of long-term glucose abnormalities in patients with acute myocardial infarction

✍ Scribed by M. Wallander; K. Brismar; J. Öhrvik; L. Rydén; A. Norhammar

Book ID: 105818501
Publisher: Springer
Year: 2006
Tongue: English
Weight: 175 KB
Volume: 49
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s00125-006-0386-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abnormal glucose tolerance – a common ri

Abnormal glucose tolerance – a common risk factor in patients with acute myocardial infarction in comparison with population-based controls

✍ M. Bartnik; K. Malmberg; A. Hamsten; S. Efendic; A. Norhammar; A. Silveira; Å. T 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Increased levels of soluble tissue facto

Increased levels of soluble tissue factor during long-term treatment with warfarin in patients after an acute myocardial infarction

✍ I. Seljeflot; M. Hurlen; H. Arnesen 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Prognostic implications of glucose-lower

Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study

✍ L. G. Mellbin; K. Malmberg; A. Norhammar; H. Wedel; L. Rydén; for the DIGAMI 2 I 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 201 KB

Plasma insulin-like growth factor I and

Plasma insulin-like growth factor I and its binding proteins 1 and 3 in postmenopausal patients with breast cancer receiving long term tamoxifen

✍ Eija I. Lahti; Mikael Knip; Timo J. Laatikainen 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 629 KB

Background. Insulin-like growth factor I (IGF-I) is a potent mitogen for breast cancer cells. The majority of IGF-I in plasma is bound to IGF binding proteins (IGFBPs), which modulate the biologic effects of IGF-I. Methods. Plasma concentrations of IGF-I, IGFBP-I, and IGFBP-3 were compared between

Insulin-like growth factor I (IGF-I) as

Insulin-like growth factor I (IGF-I) as a sensitive biomarker of catabolism in patients with gastrointestinal diseases

✍ Olgica Nedić; Vesna Malenković; Judith Anna Nikolić; Ivona Baričević 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

## Abstract Gastrointestinal ailments evoke changes in the hypothalamic‐pituitary‐adrenal (HPA) axis and modulation of hepatic protein synthesis. We examined the catabolic effect of certain primary gastrointestinal diseases and surgery on the concentration of insulin‐like growth factor I (IGF‐I). B

Relation of troponin T release kinetics

Relation of troponin T release kinetics to long-term clinical outcome in patients with acute ST segment elevation myocardial infarction treated with a percutaneous intervention

✍ Apostolos J. Karavidas; Antony D. Vrachatis; Martin A. Alpert; Dimitris J. Nikas 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

The purpose of this study was to determine the relation of troponin T release kinetics to long-term clinical outcome in patients with an acute ST segment elevation myocardial infarction treated with a primary percutaneous intervention. One hundred and four patients with typical ischemic chest pain a